Business news – Page 59
-
-
BusinessSadara cracker eyes richer chemical rewards
Joint venture between Dow and Saudi Aramco will target added value plastics and speciality chemicals
-
BusinessHealthcare firms invest in Crispr gene editing technology
Crispr licence agreements open up opportunities in drug discovery
-
BusinessNovartis reshuffle puts 120 staff at risk
Commitment to gene and cell therapy treatments emphasised as unit broken up amid pharmaceutical division refocus
-
BusinessUS government agency awards Monsanto whistleblower $22 million
Pay-out is second largest reward from US whistleblower programme
-
-
BusinessJoined-up thinking
The rift between contract medicinal chemistry and chemical development needs to be bridged
-
OpinionDon’t fear the Crispr
Does simple gene-editing mean the end of traditional medicinal chemistry? Probably not
-
BusinessFatal incidents at two chemical plants
In recent weeks three people have been killed in chemical plant accidents in Malaysia and the US
-
BusinessFDA urges labs to test all blood donations for Zika
Agency has also given emergency authorisation to two new Zika blood tests
-
BusinessPfizer to buy Astrazeneca’s antibiotics
Deal tops up Pfizer’s late-stage development pipeline, but AZ will retain biological programmes
-
BusinessPfizer gambles on $14bn Medivation deal
Cancer specialist likely just one target in hunt for marketed drugs to offset patent expiries
-
ResearchMembranes promise to slash energy needed to separate hydrocarbons
ExxonMobil-backed study allows reverse osmosis of hard-to-distinguish para-xylene and ortho-xylene
-
BusinessEU examines Dow–DuPont union
European commission probes competition implications of the planned mega-merger
-
BusinessOn the innovation horizon
Bringing disruptive technology to market requires enhanced collaboration
-
OpinionHow do companies deal with political shifts?
Political instability hits small companies hardest
-
OpinionPreparing for the future of pharma
Dave Allen discusses how scenario planning helps to define uncertainty in pharma
-
-
BusinessUS government sued over merger crackdown
Business groups challenge Obama’s steps to limit tax inversions
-
BusinessRohm and Haas fined for safety violations
Fines relate to a trimethylaluminium explosion that injured four in January